SFN satellite: Register now to network with expert speakers and view latest research

If you are unable to see the message below, click here to view.

open online version

Home Committee Speakers Program Location Commercial Opportunities SFN Satellite Meeting: Register now Register » Sign up for updates » Become a sponsor » Organised by Sponsored by Supporting Journals Dear Colleague, Register now to interact with expert speakers and international delegates "Excellent quality speakers, lots of unpublished work presented. Ideal opportunity to network with colleagues in the field." (Delegate: 2nd RNA Metabolism in Neurological Disease) Join international experts at the 3rd RNA Metabolism in Neurological Disease Meeting, immediately prior to the 2015 meeting of SFN in Chicago, to discuss the latest developments in the role of perturbed RNA metabolism in diverse neurological diseases, including ALS, FTD, SMA, FXS, DM1, DM2 and others. Register now to hear from 21 renowned invited speakers, supplemented by contributed presentations and a large poster session. You can download the full program here. We welcome your participation and look forward to welcoming you to Chicago. J. Paul Taylor, MD, Ph.D St Jude Children's Research Hospital, Memphis, USA Fen-Biao Gao, Ph.D University of Massachusetts Medical School, USA Conference Co-Chairs Speakers include Nancy M. Bonini, University of Pennsylvania, USA - Modulation of the stress response & disease susceptibility with age Robert H. Brown Jr, University of Massachusetts Medical School, USA - Modeling C9orf72 in mice: Continuing lessons and approaches to therapy Emanuele Buratti, International Centre for Genetic Engineering and Biotechnology, Italy - Roles of hnRNPs as potential regulators of TDP-43 functional properties Don Cleveland, University of California San Diego, USA - RNA as a therapeutic target in human neurodegenerative disease: ALS, spinal muscular atrophy, Huntington's disease and beyond Thomas A. Cooper, Baylor College of Medicine, USA - Expanded repeat RNA disrupts developmental programs Ted Dawson, Johns Hopkins University, USA - RNA metabolism and the intersection with protein translation in Parkinson Disease Kevin Eggan, Harvard University, USA - Loss of the mouse C9ORF72 ortholog induces systematic and neuro-inflammation Fen-Biao Gao, University of Massachusetts Medical School, USA - Understanding pathogenic mechanisms of C9ORF72 FTD/ALS: Insights from iPSC and Drosophila models Aaron Gitler, Stanford University, USA - An expanding role for RNA-binding proteins in ALS Christian Haass, Ludwig-Maximilians University Munich, Germany - Modulation of C9orf72 repeat RNA expression Kimberly Huber, University of Texas Southwestern, USA - Regulation of synaptic and circuit function by FMRP Clotilde Lagier-Tourenne, University of California San Diego, USA - Antisense oligonucleotide therapy for ALS and frontal temporal dementia caused by a gain of toxicity from hexanucleotide expansion in the C9orf72 gene Virginia Lee, University of Pennsylvania, USA - Reversing a lethal ALS-like phenotype in a new mouse model Leonard Petrucelli, Mayo Clinic Florida, USA - C9orf72 models and mechanisms of disease Laura Ranum, University of Florida, USA - BAC transgenic mouse model of C9orf72 ALS/FTD Mani Ramaswami, Trinity College, Ireland - In vivo functions of prion-domain containing, RNA regulatory proteins Joel Richter, University of Massachusetts Medical School, USA - Translational homeostasis and the fragile X syndrome Jeffrey Rothstein, Johns Hopkins University, USA - Nucleocytoplasmic transport and its modifiers: the "Tipping" point for ALS and dementia James Shorter, University of Pennsylvania, USA - Countering deleterious RNA-binding protein misfolding J. Paul Taylor, St. Jude Children’s Research Hospital, USA - Dynamic RNA-protein assemblies and neurological disease Charles Thornton, University of Rochester Medical Center, USA - Emerging RNA-based therapeutics for myotonic dystrophy Download the full program here.

As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive third-party emails. If you no longer wish to receive third-party emails from Nature Publishing Group please unsubscribe here or update your online account. For further information on technical assistance | print subscriptions | other enquiries.
Customer Service Dept. Nature Publishing Group One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Nature Publishing Group | Principal offices: London | New York | Tokyo. Worldwide offices: Basingstoke | Boston | Buenos Aires | Delhi | Madrid | Melbourne | Mexico City | Munich | Paris | San Francisco | Sao Paulo | Seoul | Shanghai | Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.